The historical rank and industry rank for Shanghai ZJ Bio-Tech Co's FCF Margin % or its related term are showing as below:
SHSE:688317'
s FCF Margin % Range Over the Past 10 Years
Min: -59.43 Med: 21.23 Max: 52.01
Current: 33.21
During the past 13 years, the highest FCF Margin % of Shanghai ZJ Bio-Tech Co was 52.01%. The lowest was -59.43%. And the median was 21.23%.
SHSE:688317's FCF Margin % is ranked better than 98.4% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs SHSE:688317: 33.21
Shanghai ZJ Bio-Tech Co FCF Margin % Related Terms
Shanghai ZJ Bio-Tech Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688317 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai ZJ Bio-Tech Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai ZJ Bio-Tech Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a FCF Margin % of -102.44% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. According to the industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #13 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 1.6%.
Is Shanghai ZJ Bio-Tech Co's FCF Margin % too high?
Shanghai ZJ Bio-Tech Co's current FCF Margin % is -102.44%. Based on the distribution chart, Shanghai ZJ Bio-Tech Co ranks #13 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #13 out of 815 companies for FCF Margin %. This places Shanghai ZJ Bio-Tech Co in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. Shanghai ZJ Bio-Tech Co's current FCF Margin % is -102.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.94, compared to a current price of ¥15.68 — trading 57.7% above its estimated fair value. The current FCF Margin % is -102.44%. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current FCF Margin % is -102.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued.
The current stock price of ¥15.68 is trading 57.7% above its estimated GF Value™ of ¥9.94.
GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688317:
FCF Margin %: -102.44%
GF Value™: ¥9.94 vs. price of ¥15.68 (57.7% above fair value)
No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
68GF Score
Get the complete analysis for SHSE:688317
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688317 has been successfully added to your 
